Researchers analyse how an antidiabetic treatment could help control tumour growth, potentially paving the way for improved cancer treatment design.
In a study, published in the open access journal Cancers, researchers from Flinders University, in collaboration with the South Australia Health and Medical Research Institute and Flinders Medical Centre, investigate the mechanisms of a type 2 diabetes medication, metformin, when used to treat colorectal cancer cells.
Understanding the mechanisms by which metformin acts as a preventative agent and disrupts cancer cell growth represents a promising advancement in exploring the clinical efficiency of this antidiabetic treatment in cancer control.
Learn more about this research: brnw.ch/21wL6dc
#ColorectalCancer #Metformin #openscience #openacces